Cited by 603Lipoproteins and Cardiovascular HealthHealth Promotion and Cardiovascular PreventionDiabetes, Cardiovascular Risks, and Lipoproteins

Validation of the Atherosclerotic Cardiovascular Disease Pooled Cohort Risk Equations

Open access
Muntner, Paul, Colantonio, Lisandro D., Cushman, Mary, Goff, David C., Howard, George, Howard, Virginia J., Kissela, Brett, Levitan, Emily B. +2 more·2014·JAMA

Abstract

IMPORTANCE: The American College of Cardiology/American Heart Association (ACC/AHA) Pooled Cohort risk equations were developed to estimate atherosclerotic cardiovascular disease (CVD) risk and guide statin initiation. OBJECTIVE: To assess calibration and discrimination of the Pooled Cohort risk equations in a contemporary US population. DESIGN, SETTING, AND PARTICIPANTS: Adults aged 45 to 79 years enrolled in the Reasons for Geographic and Racial Differences in Stroke (REGARDS) study between January 2003 and October 2007 and followed up through December 2010. We studied participants for whom atherosclerotic CVD risk may trigger a discussion of statin initiation (those without clinical atherosclerotic CVD or diabetes, low-density lipoprotein cholesterol level between 70 and 189 mg/dL, and not taking statins; n = 10,997). MAIN OUTCOMES AND MEASURES: Predicted risk and observed adjudicated atherosclerotic CVD incidence (nonfatal myocardial infarction, coronary heart disease [CHD] death, nonfatal or fatal stroke) at 5 years because REGARDS participants have not been followed up for 10 years. Additional analyses, limited to Medicare beneficiaries (n = 3333), added atherosclerotic CVD events identified in Medicare claims data. RESULTS: There were 338 adjudicated events (192 CHD events, 146 strokes). The observed and predicted 5-year atherosclerotic CVD incidence per 1000 person-years for participants with a 10-year predicted atherosclerotic CVD risk of less than 5% was 1.9 (95% CI, 1.3-2.7) and 1.9, respectively, risk of 5% to less than 7.5% was 4.8 (95% CI, 3.4-6.7) and 4.8, risk of 7.5% to less than 10% was 6.1 (95% CI, 4.4-8.6) and 6.9, and risk of 10% or greater was 12.0 (95% CI, 10.6-13.6) and 15.1 (Hosmer-Lemeshow χ2 = 19.9, P = .01). The C index was 0.72 (95% CI, 0.70-0.75). There were 234 atherosclerotic CVD events (120 CHD events, 114 strokes) among Medicare-linked participants and the observed and predicted 5-year atherosclerotic CVD incidence per 1000 person-years for participants with a predicted risk of less than 7.5% was 5.3 (95% CI, 2.8-10.1) and 4.0, respectively, risk of 7.5% to less than 10% was 7.9 (95% CI, 4.6-13.5) and 6.4, and risk of 10% or greater was 17.4 (95% CI, 15.3-19.8) and 16.4 (Hosmer-Lemeshow χ2 = 5.4, P = .71). The C index was 0.67 (95% CI, 0.64-0.71). CONCLUSIONS AND RELEVANCE: In this cohort of US adults for whom statin initiation is considered based on the ACC/AHA Pooled Cohort risk equations, observed and predicted 5-year atherosclerotic CVD risks were similar, indicating that these risk equations were well calibrated in the population for which they were designed to be used, and demonstrated moderate to good discrimination.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1001/jama.2014.2630

Cites

21 of 21 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Overall risk prediction of the ACC/AHA ASCVD risk calculator does not differ between people with and without diabetes, despite calibration variability in some subgroups.

    “Although some variability in calibration exists in various subgroups, including by sex, race, and diabetes, the overall risk prediction does not differ in those with or without diabetes (13 -16), validating the use of risk calculators in people with diabetes.”

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Research works printed but not linked: 7

  1. [2]Stone NJ Robinson J Lichtenstein AH 2013 ACC/AHA Guideline on the Treatment of Blood Cholesterol to Reduce Atherosclerotic Cardiovascular Risk in Adults: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. Circulation 12 11 2013 doi: 10.1161/1101.cir.0000437738.0000463853.0000437737a · DOI
  2. [4]Kleindorfer DO Khoury J Moomaw CJ Stroke incidence is decreasing in whites but not in blacks: a population-based estimate of temporal trends in stroke incidence from the Greater Cincinnati/Northern Kentucky Stroke Study. Stroke 7 2010 41 7 1326 1331 20489177 PMC2904073
  3. [6]Safford MM Brown TM Muntner P Asociation of race and sex with risk of incident acute coronary heart disease events in the REasons for Geographic and Racial Differences in Stroke (REGARDS) study. JAMA 2012 308 17 1768 1774 23117777 PMC3772637
  4. [12]Soliman EZ Howard G Cushman M Prolongation of QTc and risk of stroke: The REGARDS (REasons for Geographic and Racial Differences in Stroke) study. J Am Coll Cardiol 17 4 2012 59 16 1460 1467 22497826 PMC3345207
  5. [14]Luepker RV Apple FS Christenson RH Case definitions for acute coronary heart disease in epidemiology and clinical research studies: a statement from the AHA Council on Epidemiology and Prevention; AHA Statistics Committee; World Heart Federation Council on Epidemiology and Prevention; the European Society of Cardiology Working Group on Epidemiology and Prevention; Centers for Disease Control and Prevention; and the National Heart, Lung, and Blood Institute. Circulation 18 11 2003 108 20 2543 2549 14610011
  6. [16]Prineas RJ Crow RS Zhang ZM Minnesota Code Manual of Electrocardiographic Findings 2010 Springer-Verlag London, England 2nd edition ed.
  7. [28]D'Agostino RB Sr. Grundy S Sullivan LM Wilson P Validation of the Framingham coronary heart disease prediction scores: results of a multiple ethnic groups investigation. JAMA 2001 286 2 180 187 7/11/2001 11448281

Cited by

Sorted by citations

Authors
Muntner, P., Colantonio, L. D., Cushman, M., Goff, D. C., Howard, G., Howard, V. J., Kissela, B., Levitan, E. B., Lloyd-Jones, D. M., & Safford, M. M.
Affiliations
  • University of Alabama at Birmingham (US)
  • University of Vermont (US)
  • Colorado School of Public Health (US)
  • Department of Neurology and Rehabilitation Medicine, University of Cincinnati, Cincinnati, Ohio
  • Department of Preventive Medicine, Northwestern University Feinberg School of Medicine, Chicago, Illinois
Venue
JAMA
Published
2014-04-09
Volume
311
Issue
14
Pages
1406
ISSN
  • 0002-9955 (ISSN-L)
  • 0098-7484
OpenAlex
W2096849439
Cited by
603
References
21
Citations by year
2026: 25 · 2025: 38 · 2024: 49 · 2023: 40 · 2022: 53 · 2021: 60 · 2020: 59 · 2019: 48 · 2018: 31 · 2017: 47 · 2016: 61 · 2015: 59 · 2014: 30 · 2013: 1
FWCI
65.16
Type
journal article
Language
en
Open access
Locations
  • JAMA (publishedVersion)
  • PubMed (publishedVersion)
  • Europe PMC (PubMed Central) (acceptedVersion)
  • PubMed Central (acceptedVersion)
Funders
  • National Institutes of Health (UL1TR001425)
  • National Heart, Lung, and Blood Institute (R01HL080477, K24HL111154)
  • National Institute of Diabetes and Digestive and Kidney Diseases (P30DK079626)
  • National Institute of Neurological Disorders and Stroke (U01NS041588, R01NS041588)
  • National Center for Advancing Translational Sciences
  • National Institute on Minority Health and Health Disparities (P20MD006899)
Topics
  • Health Sciences › Medicine › Surgery › Lipoproteins and Cardiovascular Health
  • Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Health Promotion and Cardiovascular Prevention
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
Keywords
atherosclerotic cardiovascular disease, Pooled Cohort Equations, risk prediction model validation, calibration, discrimination (statistics), statin initiation, coronary artery disease, stroke, myocardial infarction, REGARDS study, Medicare beneficiaries, low LDL cholesterol, cardiovascular risk assessment, coronary heart disease mortality, stroke mortality
MeSH terms
Aged, Cardiovascular Diseases, Female, Humans, Hyperlipidemias, Interviews as Topic, Male, Middle Aged, Risk, United States, Cohort Studies, Incidence, Risk Assessment, Hydroxymethylglutaryl-CoA Reductase Inhibitors, Atherosclerosis, Mathematical Concepts

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review